Catalyst Wire Dossier Catalyst Wire Dossier

Paclitaxel Lipid Suspension

paclitaxel lipid suspension · Jina Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Paclitaxel Lipid Suspension, covering 2025-03-10 to 2025-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer [Phase 3]

See pricing